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ABSTRACT Cytidine deaminase (CDA) is a pyrimidine salvage enzyme that catalyzes
cytidine and deoxycytidine hydrolytic deamination to yield uridine and deoxyuridine.
Here we report the biochemical characterization of Trypanosoma brucei CDA as an
enzyme within the tetrameric class of the CDA family that efficiently deaminates cyt-
idine, deoxycytidine, and the nucleoside analogue 5-methyl-2=-deoxycytidine. In line
with previous studies, we show that RNA interference (RNAi)-mediated CDA deple-
tion impairs T. brucei proliferation when grown in pyrimidine-deficient medium,
while supplementation with thymidine or deoxyuridine restores growth, further un-
derscoring the role of this enzyme in providing deoxyuridine for dUMP formation via
thymidine kinase, the substrate required for de novo thymidylate biosynthesis. This
observation contrasts with the existence in T. brucei of a dimeric deoxyuridine 5=-
triphosphate nucleotidohydrolase (dUTPase), an essential enzyme that can produce
dUMP via the hydrolysis of dUTP/dUDP. Thus, T. brucei dUTPase-null mutants are
thymidine auxotrophs, suggesting that dUTPase might have a role in providing
dUMP for thymidylate biosynthesis. We show that overexpression of human dCMP
deaminase (DCTD), an enzyme that provides directly dUMP through dCMP deamina-
tion, does not reverse the lethal phenotype of dUTPase knockout cells, which further
supports the notion that in T. brucei, CDA is uniquely involved in providing dUMP,
while the main role of dUTPase would be the withdrawal of the excess of dUTP to
avoid its incorporation into DNA. Furthermore, we report the mitochondrial localiza-
tion of CDA, highlighting the importance of this organelle in pyrimidine metabolism.
IMPORTANCE Cytidine deaminases (CDAs) catalyze the hydrolytic deamination of
cytidine and deoxycytidine in the pyrimidine salvage pathway. In kinetoplastids, py-
rimidine metabolism has been extensively studied as a source of potential drug tar-
gets, given the fact that many of the enzymes of the pathway are essential. Thymi-
dylate (dTMP) synthesis in Trypanosoma brucei exhibits unique characteristics. Thus,
it has been suggested that the production of dUMP, the substrate for dTMP forma-
tion, is solely dependent on cytidine deaminase and thymidine kinase. Here we
characterize recombinant T. brucei CDA (TbCDA) and present evidence that indeed
the alternative route for dUMP formation via deoxyuridine 5=-triphosphate nucleoti-
dohydrolase does not have a prominent role in de novo dTMP formation. Further-
more, we provide a scheme for the compartmentalization of dTMP biosynthesis, tak-
ing into account the observation that CDA is located in the mitochondrion, together
with available information on the intracellular localization of other enzymes involved
in the dTTP biosynthetic pathway.
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Trypanosoma brucei is an extracellular protozoan parasite within the Kinetoplastidaorder and the causative agent of African trypanosomiasis. The subspecies T. brucei
rhodesiense and T. brucei gambiense are responsible for human African trypanosomiasis
(HAT), or sleeping sickness, while T. brucei brucei infects only domestic and wild animals.
Even though several drugs for treatment of the first and second stages of HAT are
currently available, severe adverse side effects, poor efficacy, and complex treatment (1,
2) are some of the reasons why there is a real need for the development of new drugs.
A well-controlled pool of deoxyribonucleotides (deoxynucleoside triphosphates
[dNTPs]) is crucial for DNA biosynthesis and replication and subsequently for cell
integrity. dUMP formation for thymidylate (dTMP) synthesis is essential for T. brucei
survival and occurs through phosphorylation of deoxyuridine by the action of T. brucei
thymidine kinase (TbTK) (3, 4). The major source of deoxyuridine (dUrd) for dUMP
formation has been described as coming from deoxycytidine (dCtd) deamination via T.
brucei cytidine deaminase (TbCDA) (3). Impairment of dTMP generation by downregu-
lation of TbTK leads to decreased dTTP levels and the so-called “thymineless death” (5).
In addition to TbTK, dihydrofolate reductase-thymidylate synthase (TbDHFR-TS), a
dimeric bifunctional enzyme responsible for the reductive methylation of dUMP to
dTMP, is also essential for parasite survival in the absence of extracellular thymidine
(dThd) (3, 4, 6).
The essential character of TbTK resides in the observation that T. brucei lacks a dCMP
deaminase (DCTD) and subsequently a route for dUMP formation through dCMP
deamination. However, dUMP can also be formed through the hydrolysis of dUTP via
T. brucei deoxyuridine 5=-triphosphate nucleotidohydrolase (TbdUTPase), an enzyme
that catalyzes the hydrolysis of both dUDP and dUTP to dUMP and Pi or PPi, respectively
(7). This apparent redundancy poses questions regarding the role of TbdUTPase in
dTMP biosynthesis. TbdUTPase has been shown to be essential (8), and knockout
parasites are dThd auxotrophs and exhibit a hypermutator phenotype (7).
Cytidine deaminase (CDA) has been described in different organisms as a pyrimidine
salvage pathway enzyme that catalyzes the hydrolytic deamination of cytidine (Ctd)
and dCtd to uridine and dUrd, respectively, and is also capable of deaminating several
nucleoside analogues used in cancer treatment, such as decitabine (5=-aza-2=-
deoxycytidine) (9), gemcitabine (2=,2=-difluoro-2=-deoxycytidine) (10), or cytarabine
(1--D-arabinofuranosylcytosine [Ara-C]) (11).
From the structural point of view, CDAs are divided in two different classes: the
homodimeric CDAs, such as Escherichia coli CDA or Arabidopsis thaliana CDA, which
consist of two identical monomers of approximately 32 kDa (12, 13), and the homote-
trameric CDAs, such as Homo sapiens CDA or Bacillus subtilis CDA, which consist of four
identical polypeptides of approximately 15 kDa (14, 15). In all cases, the molecular mass
of the native enzyme is 60 to 64 kDa, and each subunit coordinates a zinc ion in the
active site, which in dimeric CDAs like that of E. coli is formed with the contribution of
residues from the so-called “broken active site” of the other monomer (12), whereas in
tetrameric CDAs like that of B. subtilis, it is built through a series of intersubunit
interactions (15–17).
Here we aim to study the contribution of TbCDA (3) and TbdUTPase (7, 8) to dUMP
formation for dTMP synthesis. We report the biochemical characterization of TbCDA
and the confirmation of its essential role in dUMP formation for dTMP synthesis via
TbTK. On the other hand, we present data indicating that the essential character of
TbdUTPase is mainly related to the maintenance of cellular dUTP concentrations, while
TbCDA and TbTK would be the enzymes uniquely involved in dUMP production. A
scheme for the intracellular compartmentalization of dTTP synthesis in T. brucei is
proposed herein.
RESULTS
TbCDA belongs to the homotetrameric class of the CDA family and efficiently
deaminates cytidine and deoxycytidine. In an effort to characterize TbCDA
(Tb927.9.3000), the coding sequence was cloned in pET28a in order to express a
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recombinant His tag fusion protein for further purification and kinetic analysis. TbCDA
was efficiently expressed in a soluble form, and the protein was purified by metal-
binding affinity chromatography followed by size exclusion chromatography (see
Table S1 and Fig. S1 in the supplemental material). The final product was analyzed by
SDS-PAGE, revealing a major band of 21.5 kDa with minor contaminants, which was
identified as TbCDA by tryptic digestion and peptide fingerprinting.
Analysis of TbCDA by mass spectrometry revealed a major peak with an m/z value
of 21,192.059, corresponding to the theoretical mass of the His tag fusion protein
(21,334.2 Da), and a second peak with an m/z value of 42,568.411, which could
correspond to the molecular mass of the dimer, although a tetrameric quaternary
structure could not be discarded: given the fact that the interactions among the
different subunits are ionic in nature and subsequently weak, the trimeric and tetra-
meric structures could have been unstable after ionization and therefore undetectable.
The potential oligomeric structure of TbCDA was further analyzed by gel filtration,
resulting in a major peak with a molecular mass of approximately 77.7 kDa, indicating
that it is a member of the homotetrameric class of the CDA family. All the CDA
superfamily members possess a zinc binding motif (H/C-X-E-X24-36P-C-X2-4C) (18, 19)
with a histidine and two cysteine residues coordinating the zinc ion in the case of the
homodimeric class, whereas in the homotetrameric class, the metal binding motif
sequence consists of three cysteine residues (15). The alignment in Fig. 1 shows that
indeed TbCDA exhibits the following zinc binding motif conserved residues: Glu72,
analogous to the human CDA residue Glu67, which plays an important role in catalysis
(20); Pro112; and the three characteristic cysteine residues (Cys70, Cys113, and Cys116)
that coordinate the zinc ion. The alignment also shows the conservation of other
important residues present in either tetrameric or dimeric CDAs, such as Phe42, Asn60,
Glu62, Ala71, and Phe158, which are involved in substrate binding, as well as Ser40,
Arg117, Gln118, Glu122, and Leu154, which are important for tetramer/dimer interac-
tions (15). Tyr39 is conserved in tetrameric CDAs and is important for the stabilization
FIG 1 Sequence alignment of cytidine deaminase orthologs from several organisms, including Trypanosoma brucei (XP_803607.1), Homo sapiens (NP_001776.1),
Bacillus subtilis (KOS70912.1), Escherichia coli (KHJ23847.1), and Arabidopsis thaliana (CAA06460.1). Amino acids involved in the zinc binding site are highlighted
with solid triangles, residues responsible for substrate binding are denoted by solid squares, amino acids involved in domain-domain interactions are indicated
by asterisks, and conserved tyrosine residues in tetrameric CDAs are marked with solid circles. The alignment was visualized with JalView according to the
Clustal color scheme (http://www.jalview.org/help/html/colourSchemes/clustal.html).
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of the quaternary structure (17). Likewise, the Tyr66 NH group is hydrogen bonded with
the 5=-OH of the substrate (20) and is also conserved in tetrameric CDAs.
Table 1 shows the kinetic parameters for recombinant TbCDA determined for Ctd,
dCtd, and 5-methyl-2=-deoxycytidine (5-Met-dCtd) as the substrates and measured as
described previously (14). The enzyme exhibits Michaelis-Menten kinetics, and the Km
values obtained for dCtd were similar to those of the human, E. coli, and A. thaliana
CDAs (13). Table 2 presents the kinetic parameters previously published for human (14),
E. coli (13), A. thaliana (13), and B. subtilis (16) CDAs. Neither dCMP nor dCTP was a
substrate of the enzyme.
TbCDA activity was also measured for the nucleoside analogue 5-Met-dCtd, giving
Km values on the same order as human CDA (21). 5-Met-dCtd was the substrate for
which TbCDA shows the highest affinity, followed by dCtd and Ctd. In contrast, Vmax
values were in the order Ctd  dCtd  5-Met-dCtd. Figure S2 in the supplemental
material shows the Michaelis-Menten plots obtained for each substrate assayed.
A comparative analysis of catalytic efficiency (kcat/Km) indicated that dCtd is almost
as good a substrate as Ctd. The best substrate for dimeric CDAs has been reported to
be dCtd, while for human CDA, Ctd is slightly better (13), although other tetrameric
CDAs like the enzyme from B. subtilis are more efficient with dCtd (16). There was no
evidence of product inhibition.
TbCDA and not TbdUTPase has a major role in the provision of dUMP for de
novo thymidylate biosynthesis. Previous data (3) have shown that the knockout of
TbCDA in bloodstream forms (BFs) gives rise to dThd/dUrd auxotrophy, thus suggesting
an essential role in dTMP biosynthesis. The role postulated for TbCDA is the deamina-
tion of dCtd to render dUrd, which is subsequently phosphorylated by TbTK to dUMP,
the substrate for dTMP biosynthesis. This would be the sole route for provision of dUMP
since T. brucei lacks dCMP/dCTP deaminases. In line with this hypothesis, Leija et al.
demonstrated that overexpression of human dCMP deaminase (DCTD) in a TbTK-null
cell line restores cell growth by directly providing dUMP (3). Here we have performed
RNA interference (RNAi)-mediated depletion of TbCDA in T. brucei BF cells (TbBF
CDA-RNAi), and in agreement with the observations obtained for CDA-null mutants (3),
the depletion of the enzyme resulted in growth defects when grown in HMI-9
pyrimidine-deficient medium (Fig. 2A and B). Supplementation of TbCDA-depleted cells
with dThd or dUrd restored growth to levels similar to those obtained in parental cells
(Fig. 2C to F), further supporting the role of this enzyme in de novo dTMP biosynthesis.
TABLE 1 Kinetic parameters for different substrates of TbCDA determined at 282 nm
Substrate
TbCDA
Km (M)
Vmax
(mol·min1·mg1) Kcat (min1)
Kcat/Km
(M1·min1) Vmax/Km
Deoxycytidine 52.3  4.5 34.9  0.8 745.6  17.6 14.3 0.67
Cytidine 199.5  9.0 126.1  3.4 2,690.4  72.0 13.5 0.63
5-Methyl-2=-deoxycytidine 24.5  3.3 5.9  0.2 125.6  4.8 5.1 0.24
TABLE 2 Kinetic parameters published for different CDAs
dCtd or Ctd
Result for CDA froma:
H. sapiensb A. thalianac E. colid B. subtilise
Km Vmax Vmax/Km Km Vmax Vmax/Km Km Vmax Vmax/Km Km Vmax Vmax/Km
Deoxycytidine 39 45.5 1.17 75 49 0.65 60 444 7.4 236 230 0.97
Cytidine 39 68.3 1.75 150 59.5 0.39 110 147 1.33 216 184 0.85
aKm values are expressed in M. Vmax values are expressed in mol·min1·mg1.
bSee reference 14.
cSee reference 13.
dSee reference 13.
eSee reference 16.
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However, T. brucei has a dimeric dUTPase, an essential enzyme that catalyzes the
hydrolysis of dUTP/dUDP to dUMP. T. brucei BF dUTPase-null mutants (TbBF DUT-KO)
have been previously reported to be dThd auxotrophs (Fig. 3A and C) (7). The role of
the enzyme has been suggested to be dual: it is involved in the provision of dUMP for
dTMP biosynthesis, and on the other hand, it maintains a correct dUTP/dTTP balance
and controls uracil incorporation into DNA (7, 8).
The question that hence arises is why cannot TbdUTPase compensate for the
deficiency in CDA? If indeed dUTPase has a central role in dUMP production and this is
related to its essential character, overexpression of human DCTD in T. brucei BF DUT-KO
FIG 2 (A) Growth curves of T. brucei BF and BF CDA-RNAi cell lines. DOX, doxycycline. (B) Western blot showing
that TbCDA silencing was stable throughout the growth curve and that TbdUTPase levels remain unchanged after
10 days of TbCDA knockdown. (C and D) Growth curve of T. brucei BF and BF CDA-RNAi cell lines supplemented
with different dThd (C) and dUrd (D) concentrations. Each point represents the mean from three biological
replicates. Error bars represent standard deviations. (E and F) Western blot analysis demonstrating decreased
TbCDA expression during supplementation with dThd and dUrd. Anti-TbCDA (1:500), anti-TbdUTPase (1:75,000),
and anti--tubulin (1:5,000) antibodies were used. A total of 5 106 parasites were loaded in each lane.
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cells grown in thymidine-deficient medium should restore adequate growth by directly
providing dUMP. However, notably T. brucei BF DUT-KO cells expressing human DCTD
died rapidly, in the same fashion as dUTPase-null mutants in the absence of dThd
(Fig. 3B and D). The localization of the ectopically expressed enzyme was determined
by immunofluorescence to be cytosolic (Fig. 3E). These observations, together with the
essential character of TbCDA, support the notion that the main role of TbdUTPase
consists in the withdrawal of the excess of dUTP in order to avoid its massive
incorporation into DNA rather than contributing to the dUMP pool for dTMP biosyn-
thesis. T. brucei BF DUT-KO cells are dThd auxotrophs because the expansion of the
dTTP pool would contribute to normalize the dUTP/dTTP ratio, thus avoiding incorpo-
ration of dUTP into DNA, an event that is highly cytotoxic (8).
FIG 3 (A) Growth curves of T. brucei BF DUT-KO and BF parasites in the presence of dThd or 5-Met-dCtd. (B) Growth curves of T. brucei BF DUT-KO
in the presence and absence of dThd and of T. brucei BF DUT-KO cells expressing human dCMP deaminase (DCTD). Each time point corresponds
to the mean for triplicate biological replicates. (C and D) Western blot analyses showing that the T. brucei BF DUT-KO cell line lacks dUTPase and
that human DCTD is successfully expressed in doxycycline-induced cells. Anti-TbdUTPase (1:75,000), anti-DCTD (1:1,000), and anti--tubulin
(1:5,000) antibodies were used. Each lane contained 5 106 parasites. (E) DCTD subcellular localization in T. brucei BFs expressing human DCTD
analyzed by immunofluorescence. Anti-DCTD and Alexa Fluor 488-conjugated goat anti-mouse antibodies were used. Mitochondria were stained
with MitoTracker Red CMXRos, and nuclei and kinetoplasts were stained with DAPI. Images were captured using an Olympus IX81 microscope
and deconvolved with Huygens Essential software (version 3.3; Scientific Volume Imaging). Images were analyzed by using Fiji software. Bar, 5 m.
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As previously mentioned, the kinetic analysis showed that TbCDA efficiently deami-
nates the nucleoside analogue 5-Met-dCtd (Table 1). Deamination catalyzed by CDA
yields dThd, which theoretically should support growth of in vitro-cultured T. brucei BF
DUT-KO parasites. T. brucei BF DUT-KO and parental BF lines were cultured in the
presence of either 2 mM 5-Met-dCtd or 600 M dThd, and parasite growth was mon-
itored for 20 days. As shown in Fig. 3A, the T. brucei BF DUT-KO line cultured with
5-Met-dCtd exhibits a comparable growth rate to cells cultured in the presence of dThd.
Hence, TbCDA efficiently deaminates pyrimidine nucleoside analogues in T. brucei and
has an essential role in the provision of dTMP.
Furthermore, when considering a potential role for dUTPase in providing dUMP for
dTMP biosynthesis, it is possible that cross talk may occur between this enzyme and
TbCDA. However, TbdUTPase levels remain unchanged in T. brucei BF CDA-RNAi cells
(Fig. 2B), reinforcing the supposition that TbdUTPase does not play an important role
in dUMP production.
TbCDA and TbDHFR-TS are located in the mitochondrion of the parasite. The
intracellular localization of TbCDA was analyzed by immunofluorescence analysis in
both procyclic forms (PFs) (Fig. 4A) and BFs (Fig. 4B) of the parasite using an affinity-
purified polyclonal anti-TbCDA antibody. In both cases, for parental cells (upper rows)
the enzyme was mostly located in the mitochondrion. In addition, PFs and BFs
overexpressing TbCDA were generated together with PFs overexpressing a TbCDA–c-
myc fusion protein. Immunofluorescence microscopy using a polyclonal anti-TbCDA
antibody and a monoclonal antibody against the c-myc epitope again points toward a
major localization of TbCDA in the mitochondrion of the parasite (Fig. 4A and B, lower
rows). The colocalization analysis in BFs was performed for the Alexa Fluor 488 and Mito
Tracker signals, giving a Pearson’s coefficient of 0.9 0.024. Figure S3 in the supple-
mental material shows the quantification of TbCDA in both PF (Fig. S3A)- and BF
(Fig. S3B)-overexpressing mutants. In addition, Western blot analysis evidenced that the
levels of the enzyme in PFs were 2-fold those observed in BFs (Fig. S3C and D).
To further understand the compartmentalization of dTMP biosynthesis in T. brucei,
we performed an immunofluorescence analysis of TbDHFR-TS, the enzyme that sub-
sequently catalyzes the synthesis of dTMP using dUMP as the substrate. A polyclonal
anti-TbDHFR-TS antibody obtained in our laboratory was used. Its localization was
determined by immunofluorescence in both PFs and BFs of the parasite to be
mostly mitochondrial (Fig. 4C). The colocalization analysis performed for the Alexa
Fluor 488 stain and Mito Tracker signals gave a Pearson’s coefficient of 0.89 0.012
in T. brucei BFs.
DISCUSSION
Here we have performed different studies aimed at resolving the contribution of
TbCDA and TbdUTPase to dUMP and dTMP formation. We have characterized recom-
binant TbCDA as an enzyme exhibiting deaminase activity on both Ctd and dCtd and
have corroborated its essential character by means of RNAi-mediated depletion of
enzyme levels. In agreement with previous results in TbCDA knockout cells (3), dThd
and dUrd rescue the defective growth of CDA-deficient cells. Based on the observations
described in the present study and taking into account available data regarding the
intracellular localization of enzymes involved in dTMP biosynthesis, we suggest that
dTTP biosynthesis in BFs occurs as depicted in Fig. 5. The figure was assembled using
the information available in TrypTag (www.tryptag.org) (22, 23) regarding epitope
tagging and intracellular localization of different enzymes involved in dTTP biosynthe-
sis, together with the observations obtained in the present study and published
information. TbCDA efficiently deaminates dCtd to dUrd mostly within the mitochon-
drion since we show using immunofluorescence microscopy that the enzyme is pre-
dominantly present in this organelle. On the other hand, we have previously shown
that TbdUTPase is nuclear (8), while in the present study we also provide evidence that
high levels of TbDHFR-TS are present in the mitochondrial matrix. Altogether the
scheme proposed involves the movement of pyrimidine nucleosides and nucleotides in
Trypanosoma brucei Cytidine Deaminase
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and out of the mitochondrion as indicated. We propose that mitochondrial dCtd is
deaminated to dUrd within the mitochondrion. dUrd is transported to the cytosol and
nucleus, where it undergoes phosphorylation by TbTK, which is present in both the
nuclear and cytosolic compartments (4). The resulting dUMP is methylated to dTMP by
TbDHFR-TS and subsequently phosphorylated by thymidylate kinase (TbTMPK) and
nucleoside-diphosphate kinase (TbNDPK) to dTTP. TbTMPK (http://www.tryptag.org/?
idTb927.8.3510) and TbNDPK (24) have been described to occur in the cytosol in
procyclics, although a nuclear localization for TbNDPK has also been suggested (24).
The scheme assumes that the mitochondrion is mostly permeable to dUrd and dUMP.
In addition, dNTPs would be able to cross the mitochondrial and nuclear membranes
in order to satisfy the requirements for kinetoplast and nuclear DNA replication. The
role of the mitochondrion in dTMP biosynthesis has been previously documented in
other organisms. Mitochondria are a major site for folate and dTMP synthesis in plants
(25), which also contain a bifunctional DHFR-TS, similar to parasitic protozoa (26), and
FIG 4 TbCDA and TbDHFR-TS intracellular localization. Immunofluorescence analysis showing the subcellular localization of TbCDA in PF
(A) and BF (B) parental cell lines, BFs and PFs overexpressing the enzyme (T. brucei BF CDA-OE and PF CDA-OE, respectively), and PFs
overexpressing TbCDA-c-myc (T. brucei PF CDA-cmyc). (C) Immunofluorescence analysis of TbDHFR-TS localization in BFs and PFs. The
signal was detected with either anti-TbCDA or anti-TbDHFR-TS and Alexa Fluor 488-conjugated goat anti-rabbit or anti-c-myc and Alexa
Fluor 488-conjugated goat anti-mouse antibodies. Mitochondria were stained with MitoTracker Red CMXRos, and nuclei and kinetoplasts
were stained with DAPI. Images were captured using an Olympus IX81 microscope and deconvolved with Huygens Essential software
(version 3.3; Scientific Volume Imaging). Images were analyzed by using Fiji software. DIC, differential interference contrast. Bar, 5 m.
Moro-Bulnes et al.
July/August 2019 Volume 4 Issue 4 e00374-19 msphere.asm.org 8
 o
n
 Septem
ber 17, 2019 at INST PARASITO
LO
G
IA Y
http://m
sphere.asm
.org/
D
ow
nloaded from
 
a de novo dTMP biosynthesis pathway has been identified in human mitochondria
which contain a novel mitochondrial dihydrofolate reductase (27). In addition, it is
interesting to highlight that T. brucei lacks a serine hydroxymethyl transferase (SHMT),
the enzyme responsible for completing the dTMP cycle. It has been proposed that in
this parasite, mitochondrial 5,10-methylene-tetrahydrofuran (THF) is obtained by the
glycine cleavage pathway (28). Mitochondrial formate could be reconverted into formyl
and methylene THF cofactors by the trifunctional C1-THF synthase. Indeed T. brucei has
a single C1-THF synthase (Tb927.7.1600) that has been predicted to be located in the
mitochondrion (http://www.tryptag.org/?idTb927.7.1600), thus further justifying the
localization of enzymes involved in dUMP biosynthesis in this organelle. With regard to
TbdUTPase, previous studies did not allow the pinpointing of the exact contribution of
the enzyme to dUMP formation for dTMP biosynthesis. The RNAi-mediated downregu-
lation of the enzyme did not result in perturbed dTTP levels (8), although null mutants
were dThd auxotrophs. However, the recent studies performed by Leija et al. (3),
together with the data presented here, strongly suggest that the route for dUMP
formation via TbTK is essential and that TbdUTPase cannot compensate for the
lack of dUrd formation and phosphorylation to dUMP. Altogether, we propose that
TbdUTPase, which appears to be located in the nucleus, would be solely responsible for
the maintenance of the dUTP/dTTP ratio, thus controlling dUTP incorporation during
replication, while TbCDA and TbTK are uniquely involved in dUMP formation necessary
for dTMP biosynthesis. The present information highlights singular aspects of dTMP
synthesis in T. brucei that may be taken into account in the design of novel therapeutic
strategies for the treatment of trypanosomal diseases.
MATERIALS AND METHODS
Overexpression and purification of recombinant CDA from T. brucei. The coding sequence for
CDA of T. brucei was amplified by PCR from genomic DNA from the T. brucei brucei 427 strain using a pair
of gene-specific primers, 5=-GCC ATA TGC AAT GCT CAT CAT TGA AGA CC-3= (NdeI restriction site
underlined) and 5=-GCG GAT CCT CAG AAA GTT CCT GGA CAC C-3= (BamHI restriction site underlined),
designed using the sequence found in the TriTryp database (Tb927.9.3000) and cloned in the pET-28a
expression vector (Novagen), which allows an N-terminal His tag fusion protein to be obtained, yielding
the pGRV182 construct. Induction of TbCDA was performed in E. coli BL21(DE3) cells harboring pGRV182
with 1 mM IPTG (isopropyl--D-thiogalactopyranoside) when an optical density at 600 nm of 0.6 was
reached; the culture was incubated for 4 h at 37°C. Cells from 2 liters of culture were harvested by
centrifugation at 8,000 rpm for 15 min at 4°C and stored at –80°C until use. For purification, the cell pellet
was resuspended in buffer A (20 mM potassium phosphate, pH 7.4, 0.5 M NaCl, 20 mM imidazole)
FIG 5 Intracellular compartmentalization of dTTP synthesis in T. brucei. Black arrows indicate the reaction catalyzed
by each enzyme. Dashed black arrows refer to a series of reactions catalyzed by several enzymes that may occur
in the cytosol. CDA, cytidine deaminase (Tb927.9.3000); DHFR-TS, dihydrofolate reductase-thymidylate synthase
(Tb927.7.5480); TK, thymidine kinase (Tb927.10.880); dUTPase, deoxyuridine 5=-triphosphate nucleotidohydrolase
(Tb927.7.5160).
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supplemented with a cocktail of protease inhibitors (Complete Mini, EDTA-free protease inhibitor cocktail
tablets; Roche). Cells were lysed by sonication and centrifuged at 13,000 rpm for 30 min at 4°C, and the
soluble fraction was loaded on a 1-ml HisTrap column connected to a fast protein liquid chromatography
(FPLC) system (Pharmacia LKB Biotechnology). After washing, protein was eluted using an imidazole
gradient from 20 mM to 1 M at a flow rate of 0.25 ml·min1. Fractions containing TbCDA were pooled,
and buffer was exchanged with 50 mM Tris-HCl (pH 7.5) using a PD-10 column (GE Healthcare).
TbCDA enzymatic assays. Cytidine deaminase activity was assayed spectrophotometrically by
measuring the decrease in absorbance at 282 nm, as previously described (14). A concentration of 0.125
M TbCDA was incubated in 50 mM Tris-HCl (pH 7.5) plus 1 mM dithiothreitol (DTT) with the different
substrates assayed (cytidine [Sigma; D-3897], deoxycytidine [Sigma; C-4654], and 5-methyl-2=-
deoxycytidine [Santa Cruz Biotechnology; sc-278256]) in a total volume of 1 ml with a rapid kinetics
accessory (Hi-Tech Scientific) attached to a spectrophotometer (Cary 50), which was in turn connected
to a computer for data acquisition and storage. Protein concentration was determined by the method of
Bradford (29).
Size exclusion chromatography. The molecular weight (MW) of recombinant TbCDA was deter-
mined by gel filtration using a Superdex 200 column (GE Healthcare) connected to an FPLC system
(AKTApurifier; GE Healthcare). The column was equilibrated and eluted with 50 mM phosphate buffer (pH
7.4) plus 150 mM NaCl. The following molecular weight markers (Sigma) were used: cytochrome c (MW,
12.4 kDa), carbonic anhydrase (MW, 29 kDa), bovine serum albumin (MW, 66 kDa), alcohol dehydroge-
nase (MW, 150 kDa), -amylase (MW, 200 kDa), and blue dextran (MW, 2,000 kDa). Samples of 500 l of
either TbCDA or the appropriate protein markers were injected into the column. The size of the subunit
was analyzed on 12% polyacrylamide gels by SDS-PAGE. Proteins were stained with Coomassie blue.
Antibody generation. Polyclonal antibodies against TbCDA and TbDHFR-TS were generated by
immunizing rabbits with denatured and purified recombinant TbCDA or TbDHFR-TS proteins. Four
inoculations of 300 g of protein were carried out in a mixture of phosphate-buffered saline (PBS) and
Freund´s adjuvant (1:1 ratio). The anti-TbCDA or anti-TbDHFR-TS sera were then collected and affinity
purified using homogeneous recombinant protein coupled to Affi-Gel 10 gel (Bio-Rad) resin, following
the manufacturer’s instructions.
Generation of cell lines.With the purpose of downregulating TbCDA via RNAi, a fragment of 518 bp
was amplified by PCR (positions 316 to 549 of the coding sequence and positions 1 to 256 of the 3=
untranslated region [UTR]) using the following primers: 5=-GCG GAT CCA AGC TTG CTG ATG CCA CAG
TCC CTC C-3= (BamHI and HindIII restriction sites underlined) and 5=-GCG TTA ACG GGC CCC ATC CCT GCT
GCT CAT TCA C-3= (ApaI and HpaI restriction sites underlined). The fragment was digested and cloned
into the HindIII and ApaI sites of pGR19 (30), and then the same fragment was digested with BamHI and
HpaI and cloned in the previous construct in an antisense orientation, yielding pGRA3. Transfection of
BFs with this construct yielded the T. brucei BF CDA-RNAi cell line.
In order to overexpress TbCDA, specific primers were used to amplify the coding sequence: 5=-GCC
ATA TGC AAT GCT CAT CAT TGA AGA CC-3= (NdeI restriction site underlined) and 5=-GCG GAT CCT CAG
AAA GTT CCT GGA CAC C-3= (BamHI restriction site underlined). The PCR product was then cloned into
the pGRV23b plasmid (31), yielding pGRV192, which was used to transfect both BF (TbBF CDA-OE) and
PF (TbPF CDA-OE) cell lines. Additionally, to overexpress TbCDA fused to a c-myc tag, the coding
sequence without the stop codon was amplified using the following primers: 5=-GCC ATA TGC AAT GCT
CAT CAT TGA AGA CC-3= (NdeI restriction site underlined) and 5=-GCG TTA ACG AAA GTT CCT GGA CAC
CTT GAG TG-3= (HpaI restriction site underlined) and cloned into the pGRV33 construct (31), yielding
pGRV193, which was used to transfect PFs, generating the T. brucei PF CDA-c-myc cell line.
With the purpose of overexpressing human DCTD, total RNA obtained from HeLa cells was used for
RT-PCR, and the resulting cDNA was amplified by PCR with a specific pair of primers, 5=-GGA TCC CAT
ATG AGT GAA GTT TCC TGC AAG-3= (NdeI restriction site underlined) and 5=-GTC ATC GGA TCC TCA CTG
AAG CTT TTG ACT CGG-3= (BamHI restriction site underlined), and subsequently cloned into the pGRV23b
plasmid (31) to yield pGRV23bDCTD. Transfection of T. brucei BF DUT-KO cells (7) with this construct
rendered the T. brucei BF DUT-KODCTD cell line.
Trypanosome growth and transfection. Both the T. brucei single-marker bloodstream form (32) and
the procyclic form cell line 449 (33) were used, which were cultured in HMI-9 that contains 80 M
thymidine (or in the case of pyrimidine-deficient experiments, HMI-9 without thymidine) supplemented
with 10% (vol/vol) fetal bovine serum at 37°C and 5% CO2 and in SDM-79 plus supplemented with 10%
(vol/vol) fetal bovine serum and 7.5 g·ml1 hemin at 28°C, respectively.
Transfections were carried out by electroporation in Cytomix buffer for BFs or Zimmerman buffer for
PF cells mixed with 5 to 10 g of NotI-linearized plasmidic DNA as previously described (32, 34), using
a BTX ECM 630 electroporator. The selection drugs used were 5 g·ml1 hygromycin for pGRA3 (BF) and
puromycin at 0.1 g·ml1 (BF) or 1 g·ml1 (PF) for pGRV192, pGRV193, and pGRV23bDCTD. Resistant
cells were induced by addition of doxycycline (1 g·ml1).
Western blot studies. Cells (5 106) for sample preparation were harvested by centrifugation and
washed in PBS (137 mM NaCl, 4 mM Na2HPO4, 1.7 mM KH2PO4, 2.7 mM KCl). Pellets were resuspended in
urea cracking buffer (6 M urea, 10 mM Na2HPO4, 1% -mercaptoethanol, pH 7) and boiled after the
addition of loading sample buffer (67.5 mM Tris-HCl, pH 6.8, 3% SDS, 10% glycerol, 5% -
mercaptoethanol). SDS-PAGE was performed, and polyvinylidene difluoride (PVDF) membranes were
incubated with rabbit polyclonal anti-TbCDA (1:500) antibody generated against recombinant T. brucei
CDA, rabbit polyclonal anti-TbdUTPase (1:75,000) antibody generated against recombinant T. brucei
dUTPase, or mouse monoclonal anti-DCTD (1:1,000 [Santa Cruz Biotechnology]) or anti--tubulin (1:5,000
[Sigma]) antibodies. Bound antibodies were revealed by using goat anti-rabbit IgG (1:5,000) or goat
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anti-mouse IgG (1:3,000) antibodies (Promega) and the ECL enhanced chemiluminescence detection kit
(Amersham Pharmacia Biotech).
Immunofluorescence studies. Intracellular localization of DCTD, TbCDA, and TbDHFR-TS was stud-
ied by immunofluorescence analysis. Log-phase parasites were harvested, and after 15 min of incubation
with MitoTracker Red CMXRos (Invitrogen), parasites were mounted on poly-L-lysine-coated slides, fixed
with 4% p-formaldehyde at room temperature in wash solution (1 PBS, 0.2% Tween 20) for 20 min,
washed, and then blocked and permeabilized with 1% blocking reagent (Roche) containing IGEPAL 0.1%
for 75 min. Next, the immunofluorescence assay was performed using either mouse monoclonal anti-
DCTD (1:100 [Santa Cruz Biotechnology]), rabbit polyclonal anti-TbCDA (1:100 for PF and 1:50 for BF),
rabbit polyclonal anti-TbDHFR-TS (1:1,000 for PF and 1:500 for BF), or mouse monoclonal anti-c-myc
(1:100 [Sigma]) primary antibodies in blocking solution. Alexa Fluor 488 goat anti-rabbit (1:40 [Sigma]) or
Alexa Fluor 488 goat anti-mouse (1:40 [Sigma]) was used as the secondary antibody. The slides were
dehydrated in methanol for 1 min and mounted with Prolong Gold antifade reagent with DAPI (4=,6-
diamidino-2-phenylindole [Invitrogen]). Vertical stacks of 30 to 40 slices were captured using an Olympus
wide-field microscope and Cell-R IX81 software. Images were deconvolved and pseudocolored with
Huygens Essential software (version 3.3; Scientific Volume Imaging). Images were analyzed by using Fiji
software (version 1.5e; ImageJ) (35). Colocalization analysis was performed by using the JACoP plug-in
(36) calculating the Pearson’s correlation coefficient. Given values are the mean of values from at least
20 cells.
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